Inossia’s Quality Management System ISO 13485 recertified
August 09, 2024 – In May Inossia had an external recertification audit of our Quality Management System for Medical Devices, ISO 13485:2016. RISE Research Institutes of Sweden AB carried out the audit. The ISO 13485:2016 certification was recertified without any problems. Today we got our certificate. See the certificate
Inossia at GRIBOI – Sardinia Spine in Cagliari, Italy
June 12-14, 2024 – Inossia was present at the Interdisciplinary Research Conference for Injectable Osteoarticular Biomaterials (Griboi) – Sardinia Spine in Cagliari, Italy. Our CEO Malin Nilsson was one of the keynote speakers and gave a presentation about – Benefits with soft bone cement in vertebral compression fractures: pre-clinical and clinical findings.Salim Ghandour gave a presentation […]
Welcome Anette Israelsson!
February 01, 2024 – Inossia continues to grow, and we are strengthening our team by welcoming Anette Israelsson as Head of Quality Assurance & Regulatory Affairs. Anette is a chemical engineer with university studies in analytical chemistry from the University of Gothenburg. She has over 25 years of experience in the Medical Device industry in […]
Welcome Peter Fröberg!
January 03, 2024 – Inossia is growing and happy to introduce our latest team member Peter Fröberg as Head of Research and Development. Peter, MSc from the Royal Institute of Technology in Stockholm, has more than 20 years experience of product and business development within medical device, as product manager at Elekta Instrument AB, as […]
Important milestone reached – 150 patients enrolled
November 09, 2023 – Inossia is proud to announce that we have reached an important milestone.150 patients are now included in our multi-center study for osteoporosis patients treated with our new type of soft bone cement, V-Flex, including the Inossia®Cement Softener. Recruitment is now complete and the 150 patients have been operated on at ten […]
Inossia at GRIBOI in Solothurn, Switzerland
October 16-17, 2023 – Inossia was present at the Interdisciplinary Research Conference for Injectable Osteoarticular Biomaterials (Griboi) – Solothurn in Switzerland. Our CEO Malin Nilsson was one of the keynote speakers and gave a presentation about – Disc augmentation with PMMA bone cement with and without cement softener – pre-clinical and clinical review. Inossia and partner company […]
Inossia at Eurospine in Frankfurt
October 04-06, 2023 – Inossia was in Frankfurt, at the congress EUROSPINE, the Spine Society of Europe, internationally recognized as the leading event in the world of spine. Together with our partner company G21 and other professionals, we had interesting discussions related to spine care treatments. V-Flex, a flexible bone cement for percutaneous vertebral augmentation […]
Welcome Giannis Katsaros!
We are happy to introduce our latest team member Giannis Katsaros.Giannis, MSc in Materials Engineering and Biomechanics and PhD in Applied Materials Science, has experience in research and development of medical devices for the spine. During his time at Uppsala University, he also contributed to the development and testing of antipathogenic materials and products. Warm […]
Welcome Linglu Hong!
We are happy to introduce our latest team member Linglu Hong.Linglu, MSc in Bio and Nano Materials, has experience in working with research projects related to biological characterization with bone cement. Currently, she is a PhD student at Uppsala University specializing in Biomedical Engineering and will also be working as a Researcher at Inossia focusing on […]
Important milestone – First North American patient treated
July 31, 2023 Dr. Olivier Clerk-Lamalice and his team at Beam Radiology in Calgary, which is part of our multicenter clinical trial, have now treated their first patient. With this milestone, we now also have treated patients, in North America, not only in Europe. The purpose of the clinical trial is to show a statistically […]
